| Primary |
| Atrial Fibrillation |
17.9% |
| Cardiac Failure Chronic |
10.7% |
| Hiv Infection |
10.7% |
| Peritonsillar Abscess |
10.7% |
| Pulmonary Embolism |
10.7% |
| Thrombosis |
7.1% |
| Upper Respiratory Tract Infection |
7.1% |
| Antidepressant Therapy |
3.6% |
| Aortic Valve Replacement |
3.6% |
| Cardiac Failure |
3.6% |
| Dermo-hypodermitis |
3.6% |
| Hypertension |
3.6% |
| Schnitzler's Syndrome |
3.6% |
| Takayasu's Arteritis |
3.6% |
|
| Drug Interaction |
18.2% |
| Myocardial Infarction |
18.2% |
| Cerebral Haemorrhage |
9.1% |
| Haematuria |
9.1% |
| International Normalised Ratio Increased |
9.1% |
| Odynophagia |
9.1% |
| Pharyngeal Haematoma |
9.1% |
| Road Traffic Accident |
9.1% |
| Sensorimotor Disorder |
9.1% |
|
| Secondary |
| Product Used For Unknown Indication |
30.9% |
| Drug Use For Unknown Indication |
18.4% |
| Atrial Fibrillation |
8.5% |
| Hypertension |
7.9% |
| Overdose |
4.8% |
| Type 2 Diabetes Mellitus |
4.0% |
| Multiple Drug Overdose |
3.9% |
| Deep Vein Thrombosis |
3.3% |
| Cardiac Failure |
3.1% |
| Prophylaxis |
2.5% |
| Diffuse Large B-cell Lymphoma |
2.2% |
| Arrhythmia |
1.7% |
| Diabetes Mellitus |
1.4% |
| Cardiomyopathy |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Nausea |
1.2% |
| Anticoagulant Therapy |
1.1% |
| Vitamin Supplementation |
1.0% |
| Vomiting |
1.0% |
| Pulmonary Embolism |
0.8% |
|
| International Normalised Ratio Increased |
17.4% |
| Renal Failure |
11.6% |
| Drug Interaction |
9.9% |
| Pulmonary Embolism |
9.9% |
| Gastrointestinal Haemorrhage |
5.8% |
| Ventricular Arrhythmia |
5.8% |
| Death |
4.1% |
| Prothrombin Time Prolonged |
4.1% |
| Rectal Haemorrhage |
4.1% |
| Pemphigoid |
3.3% |
| Calciphylaxis |
2.5% |
| Epistaxis |
2.5% |
| Hepatic Enzyme Increased |
2.5% |
| Renal Impairment |
2.5% |
| Spontaneous Haematoma |
2.5% |
| Toxic Skin Eruption |
2.5% |
| Toxicity To Various Agents |
2.5% |
| Upper Gastrointestinal Haemorrhage |
2.5% |
| Ventricular Tachycardia |
2.5% |
| Arterial Thrombosis Limb |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.7% |
| Product Used For Unknown Indication |
11.2% |
| Atrial Fibrillation |
10.6% |
| Cardiac Failure |
8.8% |
| Hypertension |
8.6% |
| Rheumatoid Arthritis |
6.2% |
| Prophylaxis |
4.5% |
| Diabetes Mellitus |
4.3% |
| Multiple Myeloma |
3.1% |
| Pain |
2.5% |
| Anticoagulant Therapy |
2.3% |
| Hypercholesterolaemia |
2.1% |
| Osteoporosis |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Diffuse Large B-cell Lymphoma |
2.0% |
| Anaemia |
1.7% |
| Cardiac Failure Chronic |
1.5% |
| Arrhythmia |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Depression |
1.3% |
|
| Cardiac Failure |
12.8% |
| Vomiting |
9.9% |
| Death |
8.2% |
| Renal Failure Acute |
7.8% |
| Pyrexia |
5.7% |
| Syncope |
5.7% |
| Pulmonary Embolism |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Drug Interaction |
3.9% |
| Pallor |
3.9% |
| Renal Failure |
3.9% |
| Hypoglycaemia |
3.5% |
| Thrombosis |
3.5% |
| Weight Decreased |
3.5% |
| Atrial Fibrillation |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Ischaemic Stroke |
3.2% |
| Septic Shock |
3.2% |
| Tremor |
3.2% |
| Ventricular Tachycardia |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
29.5% |
| Atrial Fibrillation |
12.4% |
| Product Used For Unknown Indication |
8.1% |
| Hypertension |
7.0% |
| Anticoagulant Therapy |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Fungal Infection |
4.3% |
| Pulmonary Embolism |
3.9% |
| Arrhythmia |
3.1% |
| Antiretroviral Therapy |
2.7% |
| Hiv Infection |
2.7% |
| Depression |
2.3% |
| Respiratory Tract Infection |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Thrombosis |
1.9% |
| Acute Myocardial Infarction |
1.6% |
| Deep Vein Thrombosis |
1.6% |
| Dermatitis |
1.6% |
| Gastritis |
1.6% |
| Hyperlipidaemia |
1.6% |
|
| International Normalised Ratio Increased |
34.8% |
| Drug Interaction |
22.5% |
| Overdose |
5.6% |
| Mouth Haemorrhage |
4.5% |
| International Normalised Ratio Abnormal |
3.4% |
| Pulmonary Oedema |
3.4% |
| Rectal Haemorrhage |
3.4% |
| Myocardial Infarction |
2.2% |
| Oedema Mouth |
2.2% |
| Oesophageal Ulcer Haemorrhage |
2.2% |
| Potentiating Drug Interaction |
2.2% |
| Subdural Haematoma |
2.2% |
| Unresponsive To Stimuli |
2.2% |
| Ventricular Arrhythmia |
2.2% |
| Coagulation Test Abnormal |
1.1% |
| Embolism Venous |
1.1% |
| Fall |
1.1% |
| Haematoma |
1.1% |
| Haemorrhage |
1.1% |
| Meningeal Disorder |
1.1% |
|
